Rainbow Children's Medicare Ltd

Rainbow Children's Medicare Ltd maintains a strong liquidity position, with a current ratio of 5.46, indicating the company can easily cover its short-term liabilities with its short-term assets. However, the company's liquidity risk is assessed as medium, primarily due to a negative net cash position after subtracting total debt. The debt-to-equity ratio of 0.52 suggests a moderate level of leverage, with long-term debt amounting to INR 7.64 billion against total equity of INR 14.68 billion.

In terms of profitability, the company demonstrates strong returns, with a return on equity (ROE) of 16.58% and a return on assets (ROA) of 10.24%. These figures are well above the industry median for Healthcare Facilities & Services, indicating superior operational efficiency and asset utilization. The operating margin, calculated as operating income of INR 3.52 billion on revenue of INR 15.16 billion, stands at 23.25%, further reinforcing the company's profitability.

The company's revenue is primarily concentrated in its core pharmaceutical and healthcare services segments, with no significant geographic diversification disclosed in the available data. This concentration may expose the company to regional economic or regulatory risks, though the exact geographic breakdown is not available in the current dataset.

Looking ahead, the company is projected to maintain a stable growth trajectory, with analysts forecasting a mean price target of INR 1,561.33 and a median price target of INR 1,550.00. The mean recommendation of 1.67, with 4 strong-buy and 4 buy ratings, suggests a generally positive outlook from the investment community. The company's free cash flow of INR 2.07 billion and operating cash flow of INR 3.96 billion support its ability to fund operations and potentially invest in growth opportunities.

The risk assessment indicates a low dilution potential, with no significant dilution sources identified in the available data. However, the company's capital expenditure of INR 1.46 billion in the latest period suggests ongoing investment in infrastructure or expansion. The risk of dilution remains low, with no near-term pressure expected, and no recent issuance or shelf registration disclosed in the data.

Recent events and filings do not show any material changes in the company's operations or financial position. The company's financial performance remains consistent with its historical trends, and no significant regulatory or legal issues have been disclosed in the available data.